Skip to main content
新赣江 logo

新赣江 — Investor Relations & Filings

Ticker · 920367 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2023-03-15 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920367

About 新赣江

http://www.xgjyy.com/

Jiangxi Xinganjiang Pharmaceutical Co., Ltd. specializes in the research, development, production, and distribution of a diverse range of pharmaceutical products. The company's portfolio encompasses chemical active pharmaceutical ingredients (APIs), chemical drug preparations, and traditional Chinese medicine (TCM) formulations. Its core product offerings target therapeutic areas such as cardiovascular and cerebrovascular health, digestive system disorders, and nutritional supplementation. Key products include Ginkgo Biloba extract, Vitamin C, and various gastrointestinal medications. By maintaining an integrated value chain that spans from raw material synthesis to finished dosage forms, the company ensures quality control and supply chain efficiency. It focuses on delivering high-quality healthcare solutions through continuous innovation in pharmaceutical manufacturing and formulation technology.

Recent filings

Filing Released Lang Actions
财通证券股份有限公司关于江西新赣江药业股份有限公司调整募集资金投资项目拟投入募集资金金额的核查意见
Capital/Financing Update Classification · 95% confidence The document is from a securities company acting as a sponsor for Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It discusses the adjustment of the amount of raised funds allocated to investment projects. It references regulatory approvals, fundraising details, and board meeting approvals related to the adjustment of the use of raised funds. The document is a formal verification opinion on the adjustment of the investment amount of raised funds, not a full financial report or earnings release. It is a regulatory compliance and verification document related to capital raising and fund usage. It does not contain financial statements or earnings data, nor is it a simple announcement of a report publication. Therefore, it fits best under Capital/Financing Update (CAP) as it deals with fundraising and capital allocation updates.
2023-03-15 Chinese
中汇会计师事务所（特殊普通合伙）关于江西新赣江药业股份有限公司以自筹资金预先投入募集资金投资项目和支付发行费用的鉴证报告
Regulatory Filings
2023-03-15 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 18th meeting of the 2nd Board of Directors of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to amendments to company governance documents and capital changes. The content focuses on board decisions and governance matters rather than financial results or audit opinions. It also references submission of some matters to the shareholders' meeting but is itself a board meeting resolution announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length and detail confirm it is not a brief announcement or a report publication notice, and it is not a full financial report or audit report.
2023-03-15 Chinese
股东大会通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2023 first extraordinary general meeting of shareholders (临时股东大会) for Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It details the meeting date, voting methods, agenda items including amendments to the company charter and governance rules, and procedural information for shareholders. It does not contain actual financial statements or detailed financial analysis. The document is an announcement of a shareholders meeting rather than the meeting materials or results themselves. It is also under 5,000 characters and primarily serves to notify shareholders of the meeting and agenda. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and agenda rather than solicitation materials or voting results, it aligns more closely with Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2023-03-15 Chinese
总经理工作细则
Governance Information Classification · 95% confidence The document is titled as the "General Manager Work Rules" of Jiangxi Xinganjiang Pharmaceutical Co., Ltd., approved by the company's board of directors. It details the responsibilities, authority, and procedures related to the company's general manager and senior management. The content is a governance-related internal regulation document, focusing on management roles, decision-making processes, and reporting duties. There is no financial data, audit information, or report publication announcement. It is not a report of financial results or an announcement of voting results. The document fits best under governance information as it details internal rules and governance practices of the company.
2023-03-15 Chinese
股东大会议事规则
Governance Information Classification · 95% confidence The document is titled as the "Shareholders' Meeting Rules" of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It details the procedures, rules, and regulations governing the conduct of shareholders' meetings, including the organization, voting rights, proposal submission, meeting conduct, and resolution execution. It is a governance-related document outlining internal rules and procedures rather than a report of financial results, voting outcomes, or announcements of meetings. It does not contain financial data, voting results, or meeting minutes but rather the framework for how meetings should be conducted. Therefore, it fits best under Governance Information (CGR). The document length is substantial and contains detailed governance rules, supporting this classification with high confidence.
2023-03-15 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.